Author:
González-González Alicia,Laborda-Illanes Aurora,Boutriq Soukaina,Sánchez-Alcoholado Lidia,Castellano-Castillo Daniel,Plaza-Andrades Isaac,Peralta-Linero Jesús,Isabel Queipo-Ortuño María
Abstract
In this chapter, we describe the possible link between gut microbiota, melatonin, and breast cancer disease. It is widely described that changes in melatonin production due to circadian disruption is one of the causes of breast cancer. In addition, recently it is described that dysbiosis caused by changes in the gut microbiota composition could be as well constitute an important factor to induce breast cancer. The dysbiosis process, in turn, induces the stimulation of kynurenine pathway, leading to reduced circulating melatonin levels. Therefore, in this chapter we deep into the relationship between circadian disruption, dysbiosis, and breast cancer disease. This constitutes an important step in the therapeutic approach and prevention of this pathology.
Reference106 articles.
1. Breast Cancer Prevention (PDQ®)–Patient Version - National Cancer Institute [Internet]. 2021 [citado 26 de abril de 2022]. Disponible en: https://www.cancer.gov/types/breast/patient/breast-prevention-pdq
2. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, Reiter RJ. Basic mechanisms involved in the anti-cancer effects of melatonin. Current Medicinal Chemistry. 2010;17(36):4462-4481
3. Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, et al. Extrapineal melatonin: Sources, regulation, and potential functions. Cellular and Molecular Life Sciences. 2014;71(16):2997-3025
4. Li Y, Hao Y, Fan F, Zhang B. The Role of Microbiome in Insomnia, Circadian Disturbance and Depression. Front Psychiatry. 2018;9:669
5. Rosiak J, Zawilska JB. 14-3-3 proteins--a role in the regulation of melatonin biosynthesis. Postepy Biochemii. 2006;52(1):35-41